Aberrant expression of CD56 by circulating S&eacute;zary syndrome malignant T lymphocytes

doi:10.5411/wji.v3.i3.68

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 3

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4944)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series.

Item

Count

PDF

349

HTML

2782

Figures (1-2)

189

Sum=3320

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

887

Download

737

Sum=1624

Nov 27, 2013 (publication date) through Nov 4, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Immunology

ISSN

2219-2824

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Immunol. Nov 27, 2013; 3(3): 68-71
Published online Nov 27, 2013. doi: 10.5411/wji.v3.i3.68

Full Size Figure Download Figure

Figure 1 Evolution of the percentage of circulating KIR3DL2⁺ (○) and CD56+ (□) CD4⁺ T lymphocytes among the total CD4⁺ T cell population, and of Sézary cell count (▲) from April to December. N1: November/sample 1; N2: November/sample 2.

Citation: Thonnart N, Ram-Wolff C, Bagot M, Bensussan A, Marie-Cardine A. Aberrant expression of CD56 by circulating Sézary syndrome malignant T lymphocytes. World J Immunol 2013; 3(3): 68-71
URL: https://www.wjgnet.com/2219-2824/full/v3/i3/68.htm
DOI: https://dx.doi.org/10.5411/wji.v3.i3.68